Delphia (USA)’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,272	Closed	-$208K	–	320
2022 Q3	$208K	Sell	9,272 -607	-6%	-$13.6K	0.24%	198
2022 Q2	$245K	Buy	9,879 +3,951	+67%	+$98K	0.17%	229
2022 Q1	$230K	Buy	+5,928	New	+$230K	0.17%	231